The relationship between thyrotoxicosis and sleep disorder
Not Applicable
- Conditions
- Thyrotoxicosis
- Registration Number
- JPRN-UMIN000036113
- Lead Sponsor
- Tottori university Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 76
Inclusion Criteria
Not provided
Exclusion Criteria
Patient diagnosed as sleep apnea with simple PSG Pregnant or lactating women Patients with respiratory disease Patients with heart disease Patients with cerebrovascular disease, dementia Patients with mental illness Others who judged that the research director is inappropriate as a patient
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change rate of total score of Pittsburgh Sleep Questionnaire (PSQI) before and 12,26 and 52 weeks after treatment in patients with thyrotoxicosis
- Secondary Outcome Measures
Name Time Method Sleep quality, sleeping time, sleeping time, sleep efficiency, difficulty sleeping, use of sleeping agents, difficulty during daytime awakening, change rate of SF - 36